Close



Aug 10, 2023 05:24AM
Aug 9, 2023 09:53PM
Aug 9, 2023 04:01PM
Aug 9, 2023 04:01PM
May 4, 2023 04:25PM
Apr 14, 2023 11:12AM
Apr 14, 2023 11:10AM Merus Announces Publication of an Abstract on Petosemtamab Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma for Plenary Session Oral Presentation at the AACR Annual Meeting 2023
Apr 14, 2023 11:10AM
Apr 4, 2022 08:00AM
Nov 5, 2021 05:39AM
Nov 4, 2021 09:01PM
Nov 4, 2021 09:01PM
Nov 4, 2021 04:09PM
Nov 4, 2021 04:07PM Merus N.V. Announces Proposed Public Offering of Common Shares
Nov 4, 2021 04:07PM
May 13, 2021 08:00AM
May 13, 2021 08:00AM
Jan 21, 2021 08:42AM
Jan 21, 2021 08:40AM
Jan 21, 2021 08:40AM
Jan 19, 2021 04:18PM Merus N.V. (MRUS) Announces $60M Proposed Public Offering of Common Shares
Jan 19, 2021 04:18PM
Jan 19, 2021 04:18PM
Jan 8, 2021 09:30AM
Jan 7, 2021 05:41PM
Nov 5, 2019 08:33AM
Nov 5, 2019 08:32AM
Nov 5, 2019 08:32AM Merus Announces Pricing of Public Offering of Common Shares
Aug 22, 2018 07:00AM
Aug 22, 2018 07:00AM
Jan 5, 2017 07:45AM
Jan 5, 2017 07:45AM
Dec 21, 2016 09:19AM
Nov 15, 2016 07:13AM
Nov 15, 2016 07:00AM Merus Announces Favorable Decisions in Europe and Japan for Patents Covering Genetically-Modified Mice for Common Light Chain Human Monoclonal Antibodies
Nov 9, 2016 07:00AM
Nov 7, 2016 07:00AM
Nov 3, 2016 07:00AM
Aug 8, 2016 07:00AM
Jul 12, 2016 07:00AM
Jun 1, 2016 07:00AM

922,460 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All